Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Pfaller

Showing results (391-400 of 542) with videos related to

Pageof 55
Sort By:
Journal of Clinical Microbiology|August 28, 2009
In vitro susceptibility of clinical isolates of Aspergillus spp. to anidulafungin, caspofungin, and micafungin: a head-to-head comparison using the CLSI M38-A2 broth microdilution methodM A Pfaller, L Boyken, R J Hollis, et al.
Diagnostic Microbiology and Infectious Disease|February 1, 1996
Vitek GPS card susceptibility testing accuracy using direct inoculation from BACTEC 9240 blood culture bottlesW J Howard, B J Buschelman, M J Bale, et al.
Journal of Clinical Microbiology|August 1, 1991
Candida zeylanoides: another opportunistic yeastD Levenson, M A Pfaller, M A Smith, et al.
Journal of Clinical Microbiology|January 13, 2004
Evaluation of the NCCLS M44-P disk diffusion method for determining susceptibilities of 276 clinical isolates of Cryptococcus neoformans to fluconazoleM A Pfaller, S A Messer, L Boyken, et al.
Diagnostic Microbiology and Infectious Disease|June 4, 1999
Comparative antimicrobial activity of gatifloxacin tested against Streptococcus spp. including quality control guidelines and etest method validation. Quality Control Study GroupR N Jones, D M Johnson, M E Erwin, et al.
Infection and Immunity|November 14, 2001
Antioxidant enzyme expression in clinical isolates of Pseudomonas aeruginosa: identification of an atypical form of manganese superoxide dismutaseB E Britigan, R A Miller, D J Hassett, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1988
Prospective evaluation of the Gen-Probe assay for detection of legionellae in respiratory specimensB N Doebbeling, M J Bale, F P Koontz, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 1, 1993
Comparison of fixed concentration and fixed ratio options for dilution susceptibility testing of gram-negative bacilli to ampicillin and ampicillin/sulbactamM A Pfaller, A L Barry, P C Fuchs, et al.
Journal of Clinical Microbiology|July 10, 2004
Cross-resistance between fluconazole and ravuconazole and the use of fluconazole as a surrogate marker to predict susceptibility and resistance to ravuconazole among 12,796 clinical isolates of Candida sppM A Pfaller, S A Messer, L Boyken, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 1, 1992
Error rates in cefoperazone and cefoperazone-sulbactam disk tests with Enterobacteriaceae and Pseudomonas aeruginosaD J Hardy, A L Barry, P C Fuchs, et al.
Pageof 55

Showing results (391-400 of 542) with videos related to

Sort By:
Pageof 55
Journal of Clinical Microbiology|August 28, 2009
In vitro susceptibility of clinical isolates of Aspergillus spp. to anidulafungin, caspofungin, and micafungin: a head-to-head comparison using the CLSI M38-A2 broth microdilution methodM A Pfaller, L Boyken, R J Hollis, et al.
Diagnostic Microbiology and Infectious Disease|February 1, 1996
Vitek GPS card susceptibility testing accuracy using direct inoculation from BACTEC 9240 blood culture bottlesW J Howard, B J Buschelman, M J Bale, et al.
Journal of Clinical Microbiology|August 1, 1991
Candida zeylanoides: another opportunistic yeastD Levenson, M A Pfaller, M A Smith, et al.
Journal of Clinical Microbiology|January 13, 2004
Evaluation of the NCCLS M44-P disk diffusion method for determining susceptibilities of 276 clinical isolates of Cryptococcus neoformans to fluconazoleM A Pfaller, S A Messer, L Boyken, et al.
Diagnostic Microbiology and Infectious Disease|June 4, 1999
Comparative antimicrobial activity of gatifloxacin tested against Streptococcus spp. including quality control guidelines and etest method validation. Quality Control Study GroupR N Jones, D M Johnson, M E Erwin, et al.
Infection and Immunity|November 14, 2001
Antioxidant enzyme expression in clinical isolates of Pseudomonas aeruginosa: identification of an atypical form of manganese superoxide dismutaseB E Britigan, R A Miller, D J Hassett, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1988
Prospective evaluation of the Gen-Probe assay for detection of legionellae in respiratory specimensB N Doebbeling, M J Bale, F P Koontz, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 1, 1993
Comparison of fixed concentration and fixed ratio options for dilution susceptibility testing of gram-negative bacilli to ampicillin and ampicillin/sulbactamM A Pfaller, A L Barry, P C Fuchs, et al.
Journal of Clinical Microbiology|July 10, 2004
Cross-resistance between fluconazole and ravuconazole and the use of fluconazole as a surrogate marker to predict susceptibility and resistance to ravuconazole among 12,796 clinical isolates of Candida sppM A Pfaller, S A Messer, L Boyken, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 1, 1992
Error rates in cefoperazone and cefoperazone-sulbactam disk tests with Enterobacteriaceae and Pseudomonas aeruginosaD J Hardy, A L Barry, P C Fuchs, et al.
Pageof 55